BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2049323)

  • 21. A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
    Aviles A; Delgado S
    Clin Lab Haematol; 1998 Apr; 20(2):95-9. PubMed ID: 9681219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
    Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
    J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
    Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
    J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group.
    Cosset JM; Henry-Amar M; Meerwaldt JH
    Ann Oncol; 1991 Feb; 2 Suppl 2():77-82. PubMed ID: 2049323
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
    Valagussa P; Santoro A; Bonadonna G
    Ann Oncol; 1992 Sep; 3 Suppl 4():111-5. PubMed ID: 1450071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 27. Concomitant illness in patients treated for Hodgkin's disease.
    Bookman MA; Longo DL
    Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity.
    Pavlovsky S
    Hematology; 2005; 10 Suppl 1():3-5. PubMed ID: 16188621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of Hodgkin's disease.
    Rosenberg SA
    Ann Oncol; 1994; 5 Suppl 2():17-21. PubMed ID: 8204516
    [No Abstract]   [Full Text] [Related]  

  • 31. The EORTC strategy in the treatment of Hodgkin's lymphoma.
    Eghbali H; Raemaekers J; Carde P;
    Eur J Haematol Suppl; 2005 Jul; (66):135-40. PubMed ID: 16007882
    [No Abstract]   [Full Text] [Related]  

  • 32. Hodgkin's disease: controversies and challenges for the future.
    Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
    Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
    [No Abstract]   [Full Text] [Related]  

  • 33. Hodgkin's disease.
    Longo DL; Banks PM; Hoppe RT
    Rev Invest Clin; 1994 Apr; Suppl():73-83. PubMed ID: 7886314
    [No Abstract]   [Full Text] [Related]  

  • 34. Intensive therapy and autotransplantation in Hodgkin's disease.
    Reece DE; Phillips GL
    Stem Cells; 1994 Sep; 12(5):477-93. PubMed ID: 7804123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?
    Meyer RM
    Eur J Haematol Suppl; 2005 Jul; (66):115-20. PubMed ID: 16007879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. State-of-the-art issues in Hodgkin's lymphoma survivorship.
    Baxi SS; Matasar MJ
    Curr Oncol Rep; 2010 Nov; 12(6):366-73. PubMed ID: 20734173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long-term toxicity of curative lymphoma therapy].
    Gassmann W; Slanina J
    Internist (Berl); 1993 Feb; 34(2):161-9. PubMed ID: 8454430
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.